Riskpilot← Back to searchSign inGet full accessRaytec Aktiebolag
ABActiveOrg 5563300515Tillinge VelaGeneral medical practice activities · NACE 8621Est. 19880 employees
Revenue 2024
SEK 31,1M
+65% vs 2023
EBITDA margin
5.9%
+457% vs 2023
Equity ratio
78.7%
Financial strength
Net profit 2024
SEK 1,3M
+201% vs 2023
| Revenue | SEK 31,1M | +65% |
| EBITDA | SEK 1,8M | +457% |
| Net profit | SEK 1,3M | +201% |
| Total assets | SEK 12,3M | +9% |
| Equity | SEK 9,7M | +13% |
| Employees | 0 | — |
Legal name
Raytec Aktiebolag
Org number
5563300515
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
8 juli 1988
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultationsverksamhet och forskning inom sjukvården, hemläkarjour, handel med värdepapper, detalhandel inom livsmedelsbranschen, uthyrning av bilar och motorcyklar samt dragkärror, trädgårdsmaskiner och musikinstrument. Ävensom idka därmed förenlig verksamhet.
Address
Tillinge Vela
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 589 | 14 239 | 31 886 | 18 827 | 31 077 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 236 | 2 342 | 914 | 330 | 1 839 |
| Depreciation & amort. | −304 | −225 | −578 | −433 | −346 |
| EBIT | 1 932 | 2 117 | 336 | −103 | 1 493 |
| Net financials | 53 | 42 | 176 | 181 | 154 |
| Profit before tax | 1 813 | 1 887 | 947 | 559 | 1 646 |
| Tax | −393 | −396 | −203 | −129 | −350 |
| Net profit | 1 420 | 1 491 | 744 | 430 | 1 296 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 663 | 11 840 | 13 468 | 11 306 | 12 330 |
| Equity | 6 445 | 7 765 | 8 339 | 8 588 | 9 704 |
| Long-term debt | 487 | 560 | 2 286 | 0 | 0 |
| Short-term debt | 1 492 | 1 003 | 766 | 1 122 | 1 030 |
| Total debt | 1 979 | 1 563 | 3 052 | 1 122 | 1 030 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20202024
Equity ratio
78.7%
This company
38.2%
Market median
+106% vs market
20202024
Return on equity
13.4%
This company
18.4%
Market median
+27% vs market
20202024
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
20202024
Asset turnover
2.52×
This company
1.12×
Market median
+125% vs market
20202024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HM Audit | Audit | 2022 |
| Former (1) | ||
JA | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Raytec Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Martin Labba | Audit | 0 companies |
| Johan Arne Birger Nordmark | Audit | 0 companies |
| Karl Erik Anders Öberg | Board of Directors | 0 companies |
| Lars Jan-Olov Thorsén | Deputy Board Member | 0 companies |
| Margareta Elisabeth Backström Öberg | Deputy Board Member | 0 companies |